On Thursday, the shares of Blue Cloud Softech Solutions Ltd gained 9 per cent to Rs 42.50 per share from its previous closing ...

Fieldwork is underway at the Black Dragon and Red Dragon target areas to verify historical results via mapping and sampling.

Artificial intelligence (AI) has been a game-changer for businesses, fueling innovation and transforming industries at an unprecedented pace. Over the past year, companies have scrambled to integrate ...

Strata Minerals (ASX:SMX) begins its hunt for WA’s next highgrade gold mine, kicking off drilling to test two priority ...

Despite this, over the past six months, the penny stock has appreciated by 10.70%, and in the last year, it has delivered a significant return of 34%. Shangar Decor's stock has shown impressive ...

A recent complaint by the Securities and Exchange Commission against the chief compliance officer of a Chicago-based ...

a clinical-stage biopharmaceutical company, faces challenges typical of penny stocks. Despite promising collaborations with AbbVie and GSK, its AL002 program for Alzheimer’s disease did not meet ...

Penny stock below Re 1: NBFC stock Standard Capital Markets Limited hit upper circuit on Friday for 2nd straight session in a row. Standard Capital Markets share price from high of ₹3.52 ...

The company reported a net profit of Rs 7.10 crore in FY24 compared to Rs 7.93 crore in FY23. DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this ...

The stock is up 200% from its 2024 lows and still has a solid move ahead of it, potentially gaining another 1000% or more. The news cycle reveals that management is executing well on its plans ...

Healwell AI is making significant strides towards market dominance, while the stock is trading at a fraction of the price of Tempus AI. Healwell AI derives revenues from three streams — AI and ...

Leerink Partners analyst Joseph Schwartz has maintained their bullish stance on MREO stock, giving a Buy rating ... progress being made in their clinical programs, particularly the setrusumab ...